更年期综合征治疗用药奥舒桐®在京东健康全网首发

京东健康黑板报
Feb 12

2月12日,奥锐特药业股份有限公司旗下国内首仿药物—奥舒桐®(雌二醇片/雌二醇地屈孕酮片复合包装)在京东健康全网首发。该产品作为国内首仿获批的绝经激素治疗(MHT)药品,通过补充卵巢功能衰竭缺乏的雌孕激素,为自然或术后绝经所致的围绝经期综合征提供标准化、个体化的治疗选择,填补了国内在该领域高质量仿制药物的市场空白,助力女性全生命周期健康管理,提高更年期女性的生活质量。根据国家卫健委发布的更年期保健...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10